ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 224 filers reported holding ALKERMES PLC in Q2 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,670,173 | -8.9% | 238,136 | +1.8% | 0.01% | 0.0% |
| Q2 2023 | $7,325,389 | +113225.9% | 234,038 | +2.1% | 0.01% | 0.0% |
| Q1 2023 | $6,464 | +8.5% | 229,285 | +0.5% | 0.01% | 0.0% |
| Q4 2022 | $5,959 | -99.9% | 228,037 | +5.4% | 0.01% | +14.3% |
| Q3 2022 | $4,830,000 | -19.2% | 216,319 | +7.9% | 0.01% | -22.2% |
| Q2 2022 | $5,975,000 | +31.6% | 200,563 | +16.2% | 0.01% | +50.0% |
| Q1 2022 | $4,541,000 | +19.3% | 172,596 | +5.5% | 0.01% | +20.0% |
| Q4 2021 | $3,805,000 | -25.5% | 163,576 | -1.2% | 0.01% | -28.6% |
| Q3 2021 | $5,109,000 | +28.1% | 165,646 | +1.8% | 0.01% | +40.0% |
| Q2 2021 | $3,988,000 | +30.4% | 162,638 | -0.7% | 0.01% | +25.0% |
| Q1 2021 | $3,059,000 | -10.8% | 163,771 | -4.7% | 0.00% | -20.0% |
| Q4 2020 | $3,429,000 | +25.4% | 171,876 | +4.2% | 0.01% | +25.0% |
| Q3 2020 | $2,734,000 | -16.9% | 165,011 | -2.6% | 0.00% | -20.0% |
| Q2 2020 | $3,289,000 | +42.4% | 169,469 | +5.8% | 0.01% | 0.0% |
| Q1 2020 | $2,310,000 | -8.1% | 160,220 | +30.0% | 0.01% | +25.0% |
| Q4 2019 | $2,514,000 | +5.9% | 123,219 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $2,373,000 | -11.9% | 121,648 | +1.8% | 0.00% | -20.0% |
| Q2 2019 | $2,694,000 | -50.7% | 119,538 | -20.1% | 0.01% | -54.5% |
| Q1 2019 | $5,459,000 | +23.1% | 149,595 | -0.5% | 0.01% | +10.0% |
| Q4 2018 | $4,436,000 | -34.5% | 150,337 | -5.8% | 0.01% | -23.1% |
| Q3 2018 | $6,777,000 | +0.5% | 159,677 | -2.5% | 0.01% | -7.1% |
| Q2 2018 | $6,740,000 | -27.6% | 163,757 | +2.0% | 0.01% | -26.3% |
| Q1 2018 | $9,304,000 | +2.3% | 160,521 | -3.4% | 0.02% | +5.6% |
| Q4 2017 | $9,092,000 | +3.9% | 166,118 | -3.5% | 0.02% | -5.3% |
| Q3 2017 | $8,752,000 | -14.4% | 172,140 | -2.4% | 0.02% | -17.4% |
| Q2 2017 | $10,221,000 | -3.6% | 176,313 | -2.7% | 0.02% | -8.0% |
| Q1 2017 | $10,606,000 | +9.1% | 181,296 | +3.7% | 0.02% | 0.0% |
| Q4 2016 | $9,720,000 | +28.4% | 174,884 | +8.7% | 0.02% | +19.0% |
| Q3 2016 | $7,570,000 | +14.8% | 160,951 | +5.5% | 0.02% | +5.0% |
| Q2 2016 | $6,594,000 | +37.1% | 152,579 | +8.5% | 0.02% | +33.3% |
| Q1 2016 | $4,809,000 | -57.5% | 140,644 | -1.3% | 0.02% | -58.3% |
| Q4 2015 | $11,312,000 | +37.4% | 142,504 | +1.6% | 0.04% | +28.6% |
| Q3 2015 | $8,230,000 | -3.4% | 140,284 | +5.9% | 0.03% | +3.7% |
| Q2 2015 | $8,522,000 | +11.1% | 132,456 | +5.3% | 0.03% | +22.7% |
| Q1 2015 | $7,668,000 | +6.0% | 125,764 | +1.8% | 0.02% | +4.8% |
| Q4 2014 | $7,232,000 | +34.7% | 123,489 | -1.4% | 0.02% | +31.2% |
| Q3 2014 | $5,369,000 | -19.2% | 125,234 | -5.1% | 0.02% | -15.8% |
| Q2 2014 | $6,641,000 | +31.1% | 131,957 | +14.9% | 0.02% | +26.7% |
| Q1 2014 | $5,065,000 | +12.4% | 114,883 | +3.6% | 0.02% | +15.4% |
| Q4 2013 | $4,508,000 | +11.4% | 110,873 | -7.9% | 0.01% | 0.0% |
| Q3 2013 | $4,046,000 | -2.4% | 120,353 | -16.8% | 0.01% | 0.0% |
| Q2 2013 | $4,147,000 | – | 144,601 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |